Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk R/R LBCL

Clinical trial NCT06104592 · RECRUITING

Trial details

NCT number: NCT06104592
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma Relapsed Non-Hodgkin Lymphoma

Start date: 2023-11-08
Primary completion: 2026-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.